ID   TFE2_RAT                Reviewed;         649 AA.
AC   P21677; P21676; Q08440; Q4VY47;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1991, sequence version 1.
DT   24-JUL-2024, entry version 190.
DE   RecName: Full=Transcription factor E2-alpha;
DE   AltName: Full=Immunoglobulin enhancer-binding factor E12/E47;
DE   AltName: Full=Pancreas specific transcription factor 1c;
DE   AltName: Full=Transcription factor 3;
DE            Short=TCF-3;
DE   AltName: Full=Transcription regulator Pan;
GN   Name=Tcf3; Synonyms=Pan {ECO:0000303|PubMed:2200736}, Ptf1c, Tcfe2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS E12 AND E47), AND FUNCTION.
RX   PubMed=2200736; DOI=10.1101/gad.4.6.1035;
RA   Nelson C., Shen L.-P., Meister A., Fodor E., Rutter W.J.;
RT   "Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-
RT   4 enhancer motifs.";
RL   Genes Dev. 4:1035-1043(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM E12).
RC   STRAIN=Sprague-Dawley;
RA   Wellauer P.K.;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 427-649 (ISOFORM E12).
RX   PubMed=1766666;
RA   Metz R., Ziff E.;
RT   "The helix-loop-helix protein rE12 and the C/EBP-related factor rNFIL-6
RT   bind to neighboring sites within the c-fos serum response element.";
RL   Oncogene 6:2165-2178(1991).
RN   [4]
RP   INTERACTION WITH UBE2I.
RC   STRAIN=CD Charles River; TISSUE=Aorta;
RX   PubMed=9013644; DOI=10.1074/jbc.272.6.3845;
RA   Kho C.-J., Huggins G.S., Endege W.O., Hsieh C.-M., Lee M.-E., Haber E.;
RT   "Degradation of E2A proteins through a ubiquitin-conjugating enzyme,
RT   UbcE2A.";
RL   J. Biol. Chem. 272:3845-3851(1997).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional regulator involved in the initiation of
CC       neuronal differentiation and mesenchymal to epithelial transition (By
CC       similarity). Heterodimers between TCF3 and tissue-specific basic helix-
CC       loop-helix (bHLH) proteins play major roles in determining tissue-
CC       specific cell fate during embryogenesis, like muscle or early B-cell
CC       differentiation (By similarity). Together with TCF15, required for the
CC       mesenchymal to epithelial transition (By similarity). Dimers bind DNA
CC       on E-box motifs: 5'-CANNTG-3' (By similarity). Binds to the kappa-E2
CC       site in the kappa immunoglobulin gene enhancer (By similarity). Binds
CC       to the consensus sequence CAC/GCTGT/C present, in the chymotrypsin,
CC       insulin, AP-4, and several other gene enhancer motifs (PubMed:2200736).
CC       {ECO:0000250|UniProtKB:P15806, ECO:0000250|UniProtKB:P15923,
CC       ECO:0000269|PubMed:2200736}.
CC   -!- FUNCTION: [Isoform E47]: Facilitates ATOH7 binding to DNA at the
CC       consensus sequence 5'-CAGGTG-3', and positively regulates
CC       transcriptional activity. {ECO:0000250|UniProtKB:P15923}.
CC   -!- SUBUNIT: Homodimer. Heterodimer; efficient DNA binding requires
CC       dimerization with another bHLH protein. Forms a heterodimer with TWIST1
CC       and TWIST2. Forms a heterodimer with NEUROD1; the heterodimer is
CC       inhibited in presence of ID2, but not NR0B2, to E-box element. Forms a
CC       heterodimer with TCF15; the heterodimer binds E-box element. Forms a
CC       heterodimer with MYOG; heterodimerization enhances MYOG DNA-binding and
CC       transcriptional activities. Forms a heterodimer with ATOH8; repress
CC       transcription of TCF3 and TCF3-NEUROG3 dimer-induced transactivation of
CC       E box-dependent promoters. Component of a nuclear TAL-1 complex
CC       composed at least of CBFA2T3, LDB1, TAL1 and TCF3. Interacts with
CC       NEUROD2 (By similarity). Interacts with EP300 (By similarity).
CC       Interacts with PTF1A, TGFB1I1 (By similarity). Interacts with UBE2I
CC       (PubMed:9013644). Interacts with BHLHA9 (By similarity). Interacts with
CC       ASB2; the interaction is mediated by SKP2 and targets TCF3 for Notch-
CC       induced proteasomal degradation (By similarity). Interacts with
CC       transcription factor ASCL5/AmeloD (By similarity).
CC       {ECO:0000250|UniProtKB:P15806, ECO:0000250|UniProtKB:P15923,
CC       ECO:0000269|PubMed:9013644}.
CC   -!- SUBUNIT: [Isoform E12]: Interacts with RALGAPA1 (By similarity).
CC       Interacts with FIGLA (By similarity). {ECO:0000250|UniProtKB:P15806,
CC       ECO:0000250|UniProtKB:P15923}.
CC   -!- SUBUNIT: [Isoform E47]: Forms a heterodimer with ATOH7; required for
CC       ATOH7 DNA-binding. {ECO:0000250|UniProtKB:P15923}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P15806}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=E12; Synonyms=PAN-2;
CC         IsoId=P21677-1; Sequence=Displayed;
CC       Name=E47; Synonyms=PAN-1;
CC         IsoId=P21677-2; Sequence=VSP_002157;
CC   -!- PTM: Phosphorylated following NGF stimulation.
CC   -!- PTM: Undergoes Notch-induced ubiquitination and subsequent proteasomal
CC       degradation which is mediated by ASB1 or ASB2, the substrate-
CC       recognition components of probable ECS E3 ubiquitin-protein ligase
CC       complexes. {ECO:0000250|UniProtKB:P15923}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X54549; CAA38421.1; -; mRNA.
DR   EMBL; X62323; CAA44199.1; -; mRNA.
DR   EMBL; AJ973227; CAJ00426.1; -; mRNA.
DR   EMBL; S77532; AAB21103.1; -; mRNA.
DR   PIR; A35816; A35816.
DR   PIR; B35816; B35816.
DR   PIR; I78853; I78853.
DR   RefSeq; NP_001030314.1; NM_001035237.1.
DR   RefSeq; NP_598208.2; NM_133524.2.
DR   AlphaFoldDB; P21677; -.
DR   SMR; P21677; -.
DR   BioGRID; 251063; 4.
DR   CORUM; P21677; -.
DR   STRING; 10116.ENSRNOP00000071280; -.
DR   iPTMnet; P21677; -.
DR   PhosphoSitePlus; P21677; -.
DR   PaxDb; 10116-ENSRNOP00000023473; -.
DR   GeneID; 171046; -.
DR   KEGG; rno:171046; -.
DR   UCSC; RGD:620914; rat. [P21677-1]
DR   AGR; RGD:620914; -.
DR   CTD; 6929; -.
DR   RGD; 620914; Tcf3.
DR   eggNOG; KOG3910; Eukaryota.
DR   InParanoid; P21677; -.
DR   OrthoDB; 2915397at2759; -.
DR   PhylomeDB; P21677; -.
DR   Reactome; R-RNO-525793; Myogenesis.
DR   Reactome; R-RNO-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   PRO; PR:P21677; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0000791; C:euchromatin; ISO:RGD.
DR   GO; GO:0000786; C:nucleosome; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; ISS:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:UniProtKB.
DR   GO; GO:0043425; F:bHLH transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; ISS:UniProtKB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; IPI:RGD.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0070644; F:vitamin D response element binding; ISO:RGD.
DR   GO; GO:0002326; P:B cell lineage commitment; ISS:UniProtKB.
DR   GO; GO:0048468; P:cell development; ISO:RGD.
DR   GO; GO:0006338; P:chromatin remodeling; ISO:RGD.
DR   GO; GO:0007369; P:gastrulation; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0033152; P:immunoglobulin V(D)J recombination; ISO:RGD.
DR   GO; GO:0030098; P:lymphocyte differentiation; ISO:RGD.
DR   GO; GO:0001779; P:natural killer cell differentiation; ISO:RGD.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0048541; P:Peyer's patch development; ISO:RGD.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; ISS:UniProtKB.
DR   GO; GO:0045787; P:positive regulation of cell cycle; ISS:UniProtKB.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:2000045; P:regulation of G1/S transition of mitotic cell cycle; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0033077; P:T cell differentiation in thymus; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   CDD; cd18945; bHLH_E-protein_TCF4_E2-2; 1.
DR   Gene3D; 4.10.280.10; Helix-loop-helix DNA-binding domain; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR051098; NeuroDiff_E-box_TFs.
DR   PANTHER; PTHR11793; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTOR; 1.
DR   PANTHER; PTHR11793:SF7; TRANSCRIPTION FACTOR E2-ALPHA; 1.
DR   Pfam; PF00010; HLH; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; HLH, helix-loop-helix DNA-binding domain; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; DNA-binding; Isopeptide bond; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..649
FT                   /note="Transcription factor E2-alpha"
FT                   /id="PRO_0000127469"
FT   DOMAIN          544..597
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   REGION          37..107
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          132..207
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          296..325
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          339..376
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          385..420
FT                   /note="Leucine-zipper"
FT   REGION          435..547
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           171..177
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        50..92
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        139..156
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        183..207
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        339..362
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        452..473
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        490..547
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         135
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15923"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15923"
FT   MOD_RES         351
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P15806"
FT   MOD_RES         355
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15923"
FT   MOD_RES         367
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P15806"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15923"
FT   MOD_RES         524
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P15923"
FT   CROSSLNK        494
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P15923"
FT   CROSSLNK        620
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P15923"
FT   VAR_SEQ         525..596
FT                   /note="PDEDEDDLLPPEQKAEREKERRVANNARERLRVRDINEAFKELGRMCQLHLS
FT                   TEKPQTKLLILHQAVAVILS -> STDEVLSLEEKDLRDRERRMANNARERVRVRDINE
FT                   AFRELGRMCQLHLKSDKAQTKLLILQQAVQVILG (in isoform E47)"
FT                   /evidence="ECO:0000303|PubMed:2200736"
FT                   /id="VSP_002157"
FT   CONFLICT        167
FT                   /note="L -> LA (in Ref. 1; CAA44199)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        427
FT                   /note="P -> A (in Ref. 3; AAB21103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        508
FT                   /note="D -> DH (in Ref. 3; AAB21103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        576..577
FT                   /note="ST -> NS (in Ref. 3; AAB21103)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        637
FT                   /note="P -> T (in Ref. 3; AAB21103)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P21677-2:526
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   649 AA;  67655 MW;  882F19EDB47D14EA CRC64;
     MMNQSQRMAP VGSDKELSDL LDFSMMFPLP VANGKGRPAS LAGTQFAGSG LEDRPSSESW
     GNSEQNSSSF DPSRAYSEGA HFSDSHSSLP PSTFLGAGLG GKGSERNAYA TFGRDTSVGT
     LSQAGFLPGE LGLSSPGPLS PSGVKSSSQY YTSFPSNPRR RAADGGLDTQ PKKVRKVPPG
     LPSSVYPSSS GDNYSRDATA YPSAKTPSSA YPSPFYVADG SLHPSAELWS PPGQVGFGPM
     LGDGSAPLPL APGSSSVSSG AFGGLQQQDR MGYQLHGSEV NGTLPAVSSF SAAPGTYSGT
     SGHTPPVSGA DSLLGTRGTT ASSSGDALGK ALASIYSPDH SSNNFSPSPS TPVGSPQGLP
     GTSQWPRAGA PSALSPNYDA GLHGLSKMED RLDEAIHVLR SHAVGTASEL HGLLPGHSTL
     TTSFAGPMSL GGRHAGLVSG SHPEDGLTSG ASLLHNHASL PSQPSSLPDL SQRPPDSFSG
     LGRAGVTAGA SEIKREEKED EEVTSVADAE EDKKDLKVPR TRTSPDEDED DLLPPEQKAE
     REKERRVANN ARERLRVRDI NEAFKELGRM CQLHLSTEKP QTKLLILHQA VAVILSLEQQ
     VRERNLNPKA ACLKRREEEK VSGVVGDPQL ALSAAHPGLG EAHNPAGHL
//
